PCRX Operating Cash Flow (Statement)
Pacira Biosciences Inc · Operating Cash Flow (Statement)
PCRX Operating Cash Flow (Statement)
Latest reported$187.66Mperiod ending
PCRX TTM Cash from Operations (-$24.88M → $187.66M)
TTM operating cash flow (statement)
High-resolution chart · PNG
PCRX operating cash flow (statement) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| 187,663,000 | |
| 142,215,000 | |
| 151,994,000 | |
| 141,437,000 | |
| 134,523,000 | |
| 175,747,000 | |
| 189,389,000 | |
| 203,841,000 | |
| 194,359,000 | |
| 184,622,000 | |
| 154,649,000 | |
| 149,102,000 | |
| 147,318,000 | |
| 133,625,000 | |
| 145,274,000 | |
| 126,452,000 | |
| 144,085,000 | |
| 144,413,000 | |
| 125,717,000 | |
| 149,169,000 | |
| 128,663,000 | |
| 82,905,000 | |
| 77,032,000 | |
| 56,269,000 | |
| 34,842,000 | |
| 73,229,000 | |
| 70,520,000 | |
| 65,836,000 | |
| 64,111,000 | |
| 55,058,000 | |
| 48,870,000 | |
| 44,581,000 | |
| 25,144,000 | |
| 15,090,000 | |
| 17,785,000 | |
| 18,203,000 | |
| 32,695,000 | |
| 36,580,000 | |
| 33,453,000 | |
| 33,139,000 | |
| 24,272,000 | |
| 25,382,000 | |
| 28,996,000 | |
| 24,972,000 | |
| 31,131,000 | |
| 30,698,000 | |
| 25,469,000 | |
| 6,178,000 | |
| -12,635,000 | |
| -34,163,000 | |
| -43,216,000 | |
| -58,115,000 | |
| -59,455,000 | |
| -66,374,000 | |
| -70,130,000 | |
| -56,547,000 | |
| -53,864,000 | |
| -44,558,000 | |
| -31,000,000 | |
| -29,244,000 | |
| -27,663,000 | |
| -25,271,000 | |
| -24,880,000 | |
| -18,201,000 | |
| -21,228,000 |